Israel Englander Eton Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 355,929 shares of ETON stock, worth $6.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
355,929
Previous 138,887
156.27%
Holding current value
$6.16 Million
Previous $1.83 Million
152.96%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ETON
# of Institutions
95Shares Held
15.2MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$49.4 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$33.6 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$20.4 Million0.69% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$12 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $438M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...